Revenue (Quarterly) Chart

View Revenue (Quarterly) for HITI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
April 30, 2026 130.81M
January 31, 2026 128.54M
October 31, 2025 118.21M
July 31, 2025 108.93M
April 30, 2025 96.92M
January 31, 2025 100.31M
October 31, 2024 101.26M
July 31, 2024 96.15M
April 30, 2024 91.54M
January 31, 2024 94.72M
October 31, 2023 93.62M
July 31, 2023 93.18M
April 30, 2023 87.20M
January 31, 2023 87.57M
October 31, 2022 81.35M
July 31, 2022 74.11M
Date Value
April 30, 2022 63.96M
January 31, 2022 57.01M
October 31, 2021 42.85M
July 31, 2021 39.10M
April 30, 2021 32.47M
January 31, 2021 29.77M
October 31, 2020 20.29M
July 31, 2020 17.63M
April 30, 2020 14.95M
January 31, 2020 10.42M
October 31, 2019 8.619M
July 31, 2019 6.239M
April 30, 2019 4.952M
January 31, 2019 3.757M
October 31, 2018 1.610M
July 31, 2018 1.667M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Tilray Brands, Inc. 281.71M
cbdMD, Inc. 5.554M
CannaPharmaRx, Inc. 0.2762M
Cosmos Health, Inc. 18.99M
Lexaria Bioscience Corp. 0.00